PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
29.08%
Net income growth under 50% of AVGO's 84.13%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
4.44%
D&A growth well above AVGO's 7.09%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
24.24%
Some yoy growth while AVGO is negative at -244.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
9.43%
SBC growth well above AVGO's 6.93%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-1050.00%
Negative yoy working capital usage while AVGO is 33.71%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-611.76%
Both yoy AR lines negative, with AVGO at -153.85%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-652.17%
Both reduce yoy inventory, with AVGO at -52.31%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
209.38%
AP growth well above AVGO's 16.79%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-3.57%
Negative yoy usage while AVGO is 94.79%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-166.67%
Both negative yoy, with AVGO at -80.72%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-40.45%
Negative yoy CFO while AVGO is 17.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
41.82%
CapEx growth well above AVGO's 21.23%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-101.71%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-0.14%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
250.00%
We have some outflow growth while AVGO is negative at -4900.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-252.84%
Both yoy lines negative, with AVGO at -54.55%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.20%
Buyback growth of 98.20% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.